Front Row Advisors’s GE HealthCare GEHC Stock Holding History

Front Row Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42K	Hold	20	–	–	﹤0.01%	519
2025 Q4	$1.64K	Hold	20	–	–	﹤0.01%	498
2025 Q3	$1.5K	Hold	20	–	–	﹤0.01%	499
2025 Q2	$1.48K	Hold	20	–	–	﹤0.01%	485
2025 Q1	$1.61K	Hold	20	–	–	﹤0.01%	454
2024 Q4	$1.56K	Hold	20	–	–	﹤0.01%	451
2024 Q3	$1.88K	Sell	20 -849	-98%	-$71.3K	﹤0.01%	447
2024 Q2	$67.7K	Hold	869	–	–	0.02%	234
2024 Q1	$79K	Buy	869 +849	+4,245%	+$70.6K	0.03%	207
2023 Q4	$1.55K	Sell	20 -849	-98%	-$59.5K	﹤0.01%	423
2023 Q3	$59.1K	Hold	869	–	–	0.03%	221
2023 Q2	$71K	Sell	869 -83	-9%	-$6.62K	0.03%	209
2023 Q1	$78K	Buy	+952	New	+$68K	0.04%	198

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Front Row Advisors's GEHC Position: Q1 2026 in Review

Front Row Advisors held its GE HealthCare (GEHC) position steady in Q1 2026 at 20 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #519.

Front Row Advisors first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $79K in Q1 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Front Row Advisors held 20 shares of GE HealthCare worth $1.42K as of Q1 2026.
Front Row Advisors left its GE HealthCare share count unchanged in Q1 2026.
GE HealthCare made up ﹤0.01% of Front Row Advisors's portfolio in Q1 2026, its #519 holding.
Front Row Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
Front Row Advisors's GE HealthCare position peaked at $79K in Q1 2024.
1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.